Peng Lee
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 14
- Cancer, Lipids, and Metabolism 12
- MicroRNA in disease regulation 10
- Reproductive Medicine top 1%
- Molecular Biology top 2%
- Cancer-related gene regulation 12
- Ubiquitin and proteasome pathways 8
- Obstetrics and Gynecology top 2%
-
- Prostate Cancer Treatment and Research 47
- Prostate Cancer Diagnosis and Treatment 10
-
- Estrogen and related hormone effects 16
- Co-authors
- Jonathan MelamedGarrett DanielsJian‐Jun WeiXinyu WuMarie E. MonacoEva HernandoJian-Jun WeiIman Osman
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Peng Lee
145 papers receiving 5.8k citations
Peers
Comparison fields: 5 of 161
- Cancer Research 2.0k
- Reproductive Medicine 491
- Molecular Biology 3.3k
- Obstetrics and Gynecology 367
- Pulmonary and Respiratory Medicine 1.5k
Countries citing papers authored by Peng Lee
This map shows the geographic impact of Peng Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peng Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peng Lee more than expected).
Fields of papers citing papers by Peng Lee
This network shows the impact of papers produced by Peng Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peng Lee. The network helps show where Peng Lee may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peng Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 5 | |
| 3 | 2023 | 16 | |
| 4 | 2017 | 9 | |
| 5 | 2016 | 55 | |
| 6 | 2015 | 78 | |
| 7 | 2013 | 41 | |
| 8 | 2013 | 93 | |
| 9 | 2013 | 33 | |
| 10 | 2013 | 19 | |
| 11 | 2011 | 130 | |
| 12 | 2011 | 31 | |
| 13 | 2011 | 11 | |
| 14 | 2011 | 14 | |
| 15 | 2011 | 25 | |
| 16 | 2011 | 39 | |
| 17 | 2010 | 67 | |
| 18 | 2010 | 27 | |
| 19 | 2009 | 451 | |
| 20 | Inventory based speech denoising with hidden Markov models | 2008 | 2 |
About Peng Lee
Peng Lee is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 149 papers that have together received 5.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (47 papers), Estrogen and related hormone effects (16 papers), Cancer-related molecular mechanisms research (14 papers), Cancer-related gene regulation (12 papers), Cancer, Lipids, and Metabolism (12 papers), MicroRNA in disease regulation (10 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Ubiquitin and proteasome pathways (8 papers). The work is most often cited by research in Cancer Research (2.0k citations), Reproductive Medicine (491 citations) and Molecular Biology (3.3k citations). Peng Lee has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Jonathan Melamed, Garrett Daniels, Jian‐Jun Wei, Xinyu Wu, Marie E. Monaco, Eva Hernando, Jian-Jun Wei, Iman Osman, Xuanyi Zou and Fang‐Ming Deng. Their work appears in journals such as PLoS ONE, The Journal of Urology, Oncotarget, Molecular Cancer Research and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.